infect
gastrointestin
tract
includ
distinct
clinic
entiti
gastric
infect
caus
helicobact
pylori
gastroenter
inflamm
gastric
intestin
mucosa
may
caus
variou
pathogen
bacteria
virus
parasit
toxin
includ
diarrhoea
vomit
abdomin
pain
andor
fever
differ
pathogen
may
give
rise
similar
symptom
make
aetiolog
diagnosi
import
often
selflimit
process
may
present
high
morbid
mortal
rate
especi
young
children
immunosuppress
patient
develop
countri
associ
poor
sanit
lack
run
water
nutrit
defici
popul
present
higher
morbid
mortal
rate
develop
countri
frequent
associ
foodborn
infect
rapid
success
diagnosi
pathogen
involv
clinic
pictur
import
sinc
pathogen
requir
specif
treatment
necessari
use
control
measur
avoid
dissemin
case
know
pathogen
enabl
decis
taken
whether
hospitalis
patient
treat
outpati
basi
convent
diagnost
method
use
diagnosi
gastroenter
includ
bacteri
cultur
techniqu
requir
sever
day
obtain
result
microscop
test
detect
egg
parasit
requir
high
specialis
personnel
antigen
detect
techniqu
frequent
aetiolog
agent
caus
clinic
pictur
success
cultiv
symptom
alreadi
resolv
use
manag
patient
gram
stain
techniqu
use
clinic
specimen
use
faecal
sampl
stain
usual
microbiota
bacteria
allow
observ
characterist
curv
structur
campylobact
may
valu
certain
circumst
although
perform
routin
microscop
examin
leukocyt
nonspecif
may
help
invas
enter
suspect
tabl
microbi
antigen
present
biolog
sampl
detect
quantifi
immunolog
techniqu
base
specif
antigenantibodi
reaction
wide
varieti
immunoassay
avail
diagnosi
gastrointestin
tract
infect
immunofluoresc
enzymelink
immunosorb
assay
elisa
labori
requir
train
personnel
other
membran
eia
later
flow
immunoassay
immunochromatograph
test
lfiaict
agglutin
techniqu
extrem
simpl
fast
use
specif
antibodi
test
antigen
gener
bond
well
micropl
antigen
present
clinic
sampl
combin
antibodi
bound
solid
phase
presenc
detect
addit
second
antibodi
conjug
enzym
frequent
use
enzym
peroxidas
alkalin
phosphatas
enzym
act
substrat
colorimetr
signal
produc
visibl
nake
eye
quantifi
use
spectrophotomet
gener
sensit
specif
valu
techniqu
excel
allow
simultan
process
batch
sampl
case
quantif
detect
antigen
labori
techniqu
requir
addit
multipl
reagent
wash
step
incub
time
howev
easili
autom
captur
antibodi
immobilis
membran
sampl
flow
antigen
present
retain
said
antibodi
antigenantibodi
bind
becom
appar
convent
elisa
second
antibodi
conjug
enzym
interact
enzym
substrat
caus
colour
chang
determin
consid
posit
colour
band
obtain
control
line
conjug
attach
reaction
line
antigen
attach
type
assay
sampl
process
individu
equip
specialis
personnel
requir
result
obtain
approxim
min
easili
interpret
consist
nitrocellulos
nylon
membran
like
strip
cassett
sampl
flow
capillari
action
common
sandwich
assay
two
zone
distinguish
strip
reaction
zone
antibodi
test
antigen
immobilis
control
zone
anticonjug
antibodi
immobilis
conjug
antibodi
specif
test
antigen
label
colloid
gold
molecul
colour
polystyren
microspher
antigen
present
sampl
bind
conjug
antibodi
captur
antibodi
immobilis
reaction
zone
excess
conjug
antibodi
continu
migrat
membran
retain
control
zone
neg
sampl
control
zone
colour
wherea
sampl
posit
control
reaction
zone
colour
qualit
techniqu
fast
simpl
perform
requir
special
laboratori
equip
sampl
process
individu
present
high
valu
sensit
specif
although
gener
lower
present
convent
elisa
techniqu
latex
agglutin
techniqu
base
use
latex
particl
bound
crystallis
fragment
fc
immunoglobulin
antigenbind
fragment
fab
expos
capabl
bind
antigen
found
sampl
antibodi
bind
antigen
lattic
latex
particl
produc
result
visibl
agglutin
type
techniqu
requir
specimen
process
individu
easi
perform
fast
requir
special
equip
howev
cross
reaction
may
occur
sampl
antigen
prozon
phenomena
excess
antibodi
prevent
format
framework
base
detect
antigen
use
fluorochromelabel
antibodi
extens
clinic
sampl
prepar
slide
extens
fix
incub
antibodi
specif
fluorochromeconjug
test
antigen
wash
result
read
fluoresc
microscopi
main
disadvantag
cost
reagent
labori
techniqu
molecular
techniqu
revolutionis
microbiolog
diagnosi
despit
high
cost
repres
interest
altern
convent
method
due
speed
high
sensit
specif
polymeras
chain
reaction
pcr
reproduc
physiolog
process
dna
duplic
cell
vitro
exponenti
amplifi
specif
sequenc
doublestrand
dna
sinc
invent
differ
variant
pcr
design
improv
diagnost
yield
pcr
revers
transcript
rtpcr
use
detect
amplif
rna
rna
present
sampl
use
templat
synthesis
complementari
dna
cdna
invers
transcriptas
revers
transcriptas
result
dna
amplifi
standard
pcr
quantit
pcr
qpcr
realtim
pcr
much
faster
convent
version
provid
continu
precis
quantif
dna
form
order
quantifi
dna
rna
present
sampl
necessari
perform
standard
parallel
curv
multiplex
pcr
enabl
use
multipl
probe
pair
primer
simultan
detect
differ
pathogen
system
allow
syndrom
diagnosi
gastrointestin
diseas
simultan
detect
frequent
involv
enteropathogen
includ
bacteria
virus
parasit
amplif
techniqu
avail
isotherm
amplif
nucleic
acid
amplif
take
place
constant
temperatur
involv
differ
enzym
revers
transcriptas
rnase
h
helicas
rna
polymeras
tradit
microbiolog
diagnosi
protozoa
amoeba
flagel
ciliat
coccidia
microsporidia
helminth
nematod
cestod
trematod
perform
microscop
identif
parasit
form
expel
patient
faec
increas
diagnost
yield
necessari
use
concentr
techniqu
case
specif
stain
determin
permit
diagnosi
acut
patent
infect
requir
take
serial
sampl
labori
requir
specialis
personnel
present
limit
term
sensit
specif
screen
test
parasit
antigen
faec
use
specif
antibodi
recognis
secret
surfac
wall
molecul
parasit
commercialis
system
allow
simultan
detect
differ
speci
tabl
amplif
test
genom
sequenc
greater
sensit
specif
thank
constant
characteris
genom
differ
organ
possibl
design
pcr
protocol
parasit
interest
howev
use
techniqu
one
parasit
detect
time
market
entamoeba
histolytica
caus
amoeb
dysenteri
one
possibl
caus
travel
diarrhoea
tradit
diagnosi
amoebiasi
base
mani
year
microscopi
howev
microscop
techniqu
differenti
e
histolytica
commens
amoeba
entamoeba
dispar
entamoeba
moshkovskii
pcr
techniqu
base
mostli
amplif
code
region
small
ribosom
subunit
rrna
differenti
speci
morpholog
indistinguish
entamoeba
present
excel
level
sensit
specif
hand
detect
e
histolytica
antigen
elisa
good
option
molecular
method
avail
current
differ
membran
eia
market
ict
assay
avail
detect
e
histolyticaspecif
antigen
faec
abscess
content
assay
base
detect
specif
epitop
amoeb
lectin
sensit
higher
microscop
examin
market
assay
allow
recent
frozen
stool
use
giardia
lamblia
giardiasi
caus
giardia
lamblia
parasit
diseas
great
epidemiolog
clinic
import
due
high
preval
pathogen
mainli
among
children
variou
method
antigen
detect
sensit
specif
level
superior
microscop
examin
market
diagnosi
test
also
use
screen
infant
popul
treatment
control
confirm
heal
variou
eia
market
use
monoclon
polyclon
antibodi
detect
g
lambliamembran
antigen
gsa
rapid
techniqu
costeffect
allow
process
recent
stool
faec
preserv
formalin
g
lamblia
commerci
avail
ict
assay
also
avail
howev
requir
use
fresh
frozen
stool
without
preserv
lower
sensit
elisa
assay
direct
immunofluoresc
dfi
stain
g
lamblia
use
gsa
antigenspecif
monoclon
antibodi
also
avail
cryptosporidium
homini
cryptosporidium
parvum
main
pathogen
speci
human
parasit
fundament
affect
immunosuppress
patient
caus
sever
chronic
diarrhoea
coccidiosi
tradit
detect
microscop
demonstr
oocyst
follow
special
stain
kinyoun
auraminerhodamin
variou
antigen
detect
techniqu
valid
altern
ifd
elisa
ict
techniqu
shown
specif
sensit
valu
higher
microscop
observ
howev
none
method
mention
allow
identif
speci
necessari
resort
pcr
techniqu
group
helminth
medic
import
nematod
roundworm
cestod
bandworm
trematod
stave
diagnosi
cestod
base
observ
proglottid
segment
howev
helminth
infect
diagnosi
made
microscop
identif
egg
larva
patient
stool
although
also
special
techniqu
valid
certain
helminth
graham
ribbon
diagnosi
enterobiu
vermiculari
cultiv
strongyloid
stercorali
advanc
rapid
diagnosi
intestin
helminth
signific
protozoa
antigen
detect
test
highli
develop
although
sever
studi
publish
yet
market
frequent
serolog
test
specif
antibodi
avail
diagnosi
hydatidosi
cysticercosi
fasciolosi
schistosomiasi
toxocariasi
anisakiasi
filariasi
strongyloidiasi
assay
market
other
carri
refer
centr
drawback
distinguish
current
past
infect
use
nonendem
area
often
crossreact
problem
molecular
diagnosi
multitud
pcr
protocol
design
convent
realtim
diagnosi
helminthiasi
howev
far
none
market
main
virus
produc
gastroenter
human
rotaviru
astroviru
adenoviru
noroviru
other
coronavirus
toroviru
picobirnavirus
picornavirus
aichi
viru
also
caus
gastrointestin
tract
infect
much
lower
frequenc
rapid
diagnosi
viral
gastroenter
made
detect
viral
antigen
tabl
molecular
method
base
detect
specif
gene
rotavirus
highli
contagi
rna
virus
transmit
faecalor
rout
fomit
respiratori
rout
accord
antigen
characterist
glycoprotein
compon
intern
virion
capsid
serogroup
ah
distinguish
human
infect
mainli
produc
rotaviru
serogroup
lesser
extent
serogroup
b
c
protein
constitut
virion
spicul
glycoprotein
constitu
outer
capsid
determin
exist
serotyp
p
g
respect
diagnosi
serogroup
rotaviru
infect
base
detect
viral
antigen
stool
sampl
specif
glycoprotein
moment
commerci
avail
method
detect
rotaviru
serogroup
format
avail
highli
vari
elisa
membran
eia
ict
latex
agglutin
membran
eia
ict
techniqu
latex
agglutin
suitabl
method
hospit
sporad
sampl
howev
less
sensit
convent
elisa
sensit
specif
molecular
method
base
rtpcr
diagnosi
group
rotaviru
rtpcr
market
system
use
specif
primer
gene
encod
nonstructur
protein
methodolog
also
allow
detect
rotaviru
differ
serogroup
astrovirus
nonenvelop
virus
positivesens
singlestrand
rna
genom
small
nm
diamet
starshap
electron
microscop
differ
serotyp
due
exist
antigen
cross
reaction
possibl
detect
use
groupspecif
antibodi
call
capabl
recognis
epitop
enter
adenovirus
serotyp
frequent
associ
childhood
gastroenter
specif
type
method
detect
serotyp
specif
group
method
detect
adenovirus
diagnosi
enter
adenoviru
infect
usual
establish
elisa
latex
agglutin
ict
techniqu
allow
simultan
detect
adenoviru
rotaviru
also
commerci
avail
highli
sensit
specif
pcr
method
allow
detect
characteris
enter
adenovirus
norovirus
lead
caus
nonbacteri
gastroenter
individu
age
common
caus
outbreak
acut
gastroenter
nonenvelop
virus
diamet
approxim
nm
whose
genom
made
positivesens
singlestrand
rna
genogroup
describ
genogroup
ii
iv
strain
infect
human
rtpcr
becom
refer
techniqu
diagnosi
primer
employ
enabl
amplif
viral
rna
polymeras
gene
gene
encod
capsid
protein
realtim
rtpcr
sensit
allow
detect
differenti
genogroup
ii
quickli
addit
sever
diagnost
test
base
detect
antigen
elisa
high
specif
moder
sensit
use
studi
epidem
outbreak
much
diagnosi
sporad
case
howev
avail
ict
membran
eia
high
sensit
specif
valu
clostridium
difficil
sporeproduc
anaerob
gramposit
bacillu
found
soil
intestin
tract
anim
human
colonis
children
one
year
old
healthi
adult
higher
percentag
hospitalis
adult
patient
nurs
home
c
difficil
produc
antibioticassoci
diarrhoea
symptom
may
rang
asymptomat
carrier
moder
mild
diarrhoea
pseudomembran
coliti
pathogen
strain
pathogen
locu
code
toxin
enterotoxin
encod
tcda
gene
toxin
b
potent
cytotoxin
encod
tcdb
gene
although
may
present
toxin
toxin
b
hypervirul
strain
associ
increas
morbid
mortal
rate
produc
greater
toxin
express
effici
sporul
express
binari
toxin
although
strain
current
detect
virul
characterist
patient
risk
factor
c
difficil
diarrhoea
hospitalis
nonhospitalis
rapid
detect
toxin
b
perform
initi
antibiot
treatment
appli
control
measur
prevent
spread
patient
commonli
use
method
antigen
detect
detect
glutam
dehydrogenas
gdh
eia
latex
particl
gdh
abund
antigen
cell
wall
c
difficil
detect
sensit
specif
sinc
present
toxigen
nontoxigen
strain
detect
toxin
andor
b
done
cytotox
test
ict
eia
techniqu
cytotox
test
consid
refer
method
detect
toxin
b
faec
high
sensit
specif
labori
addit
rapid
test
numer
commerci
eia
test
detect
toxin
b
recommend
use
eia
techniqu
detect
toxin
b
produc
strain
toxin
b
howev
commerci
techniqu
low
sensit
compar
cell
cultur
nucleic
acid
detect
techniqu
must
use
detect
toxin
isol
obtain
cultur
use
singl
method
sinc
requir
sever
day
grow
use
addit
direct
detect
toxin
increas
posit
detect
toxin
ab
gene
nucleic
acid
amplif
techniqu
offer
greatest
sensit
specif
although
expens
differ
realtim
pcr
allow
detect
c
difficil
toxin
b
binari
toxin
min
genexpert
present
level
accord
refer
test
greater
sensit
ict
howev
sampl
posit
molecular
method
neg
eia
cell
cultur
result
doubt
aris
clinic
mean
arriv
correct
diagnosi
costeffect
one
follow
algorithm
must
use
perform
gdh
eia
studi
presenc
toxin
use
molecular
method
posit
perform
combin
gdh
toxin
ab
eia
simultan
confirm
sampl
show
discrep
result
use
molecular
method
perform
molecular
method
sampl
escherichia
coli
may
part
normal
intestin
microbiota
variant
consid
pathovarieti
pathotyp
capac
produc
diarrhoea
caus
morbid
mortal
around
world
defin
express
one
virul
factor
enteropathogen
epec
shiga
toxin
produc
stec
also
call
enterohemorrhag
verocytotoxin
produc
includ
serotyp
enteroinvas
eiec
enterotoxigen
etec
enteroaggreg
eaec
adherentinvas
aiec
clinic
public
health
laboratori
stec
studi
defin
presenc
shiga
toxin
andor
shiga
toxin
gene
cultur
allow
e
coli
detect
cultureindepend
method
detect
other
cdc
recommend
simultan
prepar
differenti
cultur
detect
e
coli
molecular
studi
detect
faec
patient
acut
diarrhoea
acquir
commun
possibl
haemolyt
uraem
syndrom
molecular
method
avail
sent
refer
centr
follow
use
eia
stx
detect
case
differenti
enrich
broth
incub
overnight
c
stec
molecular
techniqu
detect
gene
directli
faec
sensit
method
recent
use
new
ict
perform
directli
stool
sampl
excel
result
publish
campylobact
campylobact
antigen
detect
test
develop
stool
sampl
elisa
format
microwel
plate
later
flow
ict
format
although
faster
method
cultur
less
sensit
differenti
campylobact
jejuni
campylobact
coli
molecular
method
perform
directli
faec
sensit
suffici
valid
rapid
test
ict
dipstick
detect
shigella
coloni
directli
faec
rectal
exud
thank
monoclon
antibodi
lipopolysaccharid
enterotoxin
staphylococcu
aureu
bacillu
cereu
clostridium
perfringen
detect
food
faec
strain
cultur
commerci
method
mean
revers
passiv
latex
agglutin
techniqu
eia
techniqu
helicobact
pylori
rapid
diagnosi
h
pylori
infect
differ
techniqu
use
sinc
cultur
biopsi
slow
demand
base
h
pylori
ureas
h
pylori
potent
ureas
characterist
use
sinc
discoveri
h
pylori
diagnosi
type
assay
rapid
ureas
biopsi
breath
assay
piec
biopsi
tissu
incorpor
urea
broth
gel
colour
chang
pink
minut
ureas
test
use
identifi
bacteria
obtain
cultur
mainli
use
standard
practic
endoscopi
unit
first
market
purpos
clotest
posit
result
obtain
min
h
although
could
left
h
led
loss
specif
due
ureas
posit
bacteria
current
differ
trademark
seek
shorten
time
obtain
result
perform
urea
breath
test
ubt
patient
ingest
mark
urea
breath
sampl
collect
min
ingest
h
pylori
stomach
hydrolys
urea
mark
co
releas
radioact
isotop
use
c
nonradioact
isotop
c
wide
use
measur
mass
infrar
spectromet
noninvas
test
choic
diagnosi
followup
patient
h
pylori
high
sensit
specif
detect
activ
infect
base
detect
antibodi
numer
serolog
test
detect
antih
pylori
igg
antibodi
patient
serum
main
limit
differenti
activ
infect
past
infect
kit
use
need
valid
local
use
epidemiolog
studi
gastrointestin
bleed
atroph
gastriti
gastric
cancer
malt
lymphoma
mucosa
associ
lymphoid
tissu
sinc
produc
low
bacteri
load
stomach
reduc
sensit
diagnost
test
also
test
detect
h
pylori
antibodi
urin
saliva
variabl
result
current
recommend
use
patient
manag
base
detect
antigen
faec
stool
antigen
test
noninvas
qualit
test
detect
h
pylori
antigen
elimin
faec
use
test
initi
diagnosi
infect
treatment
control
least
week
finish
treatment
epidemiolog
studi
first
kit
develop
eia
polyclon
antibodi
although
current
recommend
lower
sensit
specif
compar
use
monoclon
antibodi
numer
method
market
use
monoclon
antibodi
eia
ict
present
differ
diagnost
precis
better
result
obtain
kit
base
eia
microwel
format
consid
equival
ubt
maastricht
consensu
report
also
autom
chemiluminesc
immunoassay
result
compar
eia
sensit
specif
pretreat
diagnosi
sensit
specif
posttreat
followup
observ
studi
evalu
ict
recent
studi
commerci
ict
compar
rapid
hp
star
oxoid
found
sensit
less
specif
wherea
unigold
tm
hpylori
antigen
triniti
biotech
immunocard
stat
hpsa
meridian
sensit
specif
observ
studi
lower
valu
sensit
andor
specif
also
observ
therefor
believ
ict
need
improv
reliabl
base
molecular
method
pcr
mani
year
home
molecular
method
use
diagnosi
h
pylori
infect
differ
sampl
gastric
biopsi
faec
saliva
gastric
juic
etc
addit
allow
studi
macrolid
resist
mutat
clarithromycin
rrna
gene
fluoroquinolon
gyra
gene
tetracyclin
rrna
gene
rifabutin
rpob
gene
amoxicillin
gene
advantag
speed
greater
sensit
cultur
phenotyp
method
antibiot
sensit
detect
heterogen
resist
may
difficult
obtain
cultur
last
maastricht
consensu
sensit
studi
clarithromycin
consid
antibiot
use
first
line
treatment
region
resist
rate
greater
cultur
antibiogram
molecular
method
directli
biopsi
sever
commerci
kit
base
realtim
pcr
detect
h
pylori
directli
biopsi
method
addit
h
pylori
detect
major
mutat
confer
resist
clarithromycin
tabl
also
commerci
kit
base
pcr
follow
revers
lineblot
hybridis
tabl
commerci
system
use
molecular
method
diagnosi
helicobact
pylori
resist
clarithromycin
levofloxacin
numer
syndrom
panel
emerg
recent
year
microbiolog
diagnosi
differ
infecti
diseas
includ
diarrhoeaproduc
pathogen
within
short
time
period
deliv
result
pathogen
includ
kit
import
tool
situat
immunosuppress
patient
seriou
patient
detect
pathogen
good
sensit
highli
valuabl
detect
coinfect
differ
commerci
techniqu
detect
gastroenteritisproduc
pathogen
tabl
vari
wide
number
type
pathogen
detect
technolog
use
luminex
xtag
gpp
detect
bacteria
virus
parasit
fda
approv
ce
mark
sampl
made
h
process
includ
pretreat
nucleic
acid
extract
multiplex
pcr
pellet
hybridis
data
analysi
techniqu
increas
rate
posit
respect
convent
method
detect
mix
infect
filmarray
gi
panel
detect
bacteria
parasit
virus
fda
approv
ec
mark
consist
close
devic
requir
minim
manipul
system
perform
nucleic
acid
extract
nest
multiplex
pcr
melt
temperatur
analysi
perform
test
along
analysi
take
min
higher
rate
posit
signific
percentag
mix
infect
detect
frequent
children
year
nonhospitalis
patient
frequent
pathogen
coinfect
campylobact
epec
allplex
tm
gastrointestin
full
panel
assay
seegen
system
panel
detect
virus
bacteria
parasit
approv
use
europ
ec
mark
commerci
system
nanospher
verigen
luminex
prodess
progastro
ssc
holog
genprob
bd
max
enter
bacteri
panel
bd
entericbio
realtim
gastro
serosep
clart
enterobac
enter
pathogen
ep
test
nanospher
volatil
organ
acid
broad
rang
stabl
chemic
compound
volatil
room
temperatur
detect
patient
breath
urin
faec
sweat
proven
use
diagnosi
differ
diseas
diabet
gastrointestin
liver
diseas
lung
diseas
differ
type
cancer
variou
infect
gastrointestin
infect
h
pylori
infect
least
volatil
acid
detect
stool
sampl
patient
gastroenter
regardless
clinic
diseas
differ
marker
observ
depend
specif
type
pathogen
bangladeshi
patient
vibrio
cholera
infect
fewer
volatil
compound
observ
healthi
donor
sampl
studi
patient
infecti
diarrhoea
compar
control
hydrocarbon
terpen
patient
campylobact
infect
absenc
nonn
furan
speci
indic
infect
c
difficil
exhal
breath
analysi
patient
infect
h
pylori
volatil
compound
isobutan
ethyl
acet
observ
detect
control
compound
produc
h
pylori
vivo
metabolit
host
produc
result
infect
elev
level
hydrogen
cyanid
hcn
hydrogen
nitrat
also
report
exhal
breath
patient
h
pylori
gastriti
rapid
techniqu
extrem
valuabl
diagnosi
gastrointestin
infect
base
detect
antigen
alreadi
common
practic
clinic
microbiolog
laboratori
base
molecular
techniqu
although
pathogen
c
difficil
shiga
toxinproduc
e
coli
choos
techniqu
trademark
use
must
consid
differ
criteria
includ
pathogen
pathogen
want
detect
type
patient
intend
number
request
think
need
made
avail
equip
depart
well
cost
techniqu
go
conduct
small
number
test
individu
techniqu
eia
ict
would
appropri
number
test
high
conveni
perform
elisa
test
molecular
techniqu
detect
differ
pathogen
simultan
use
certain
group
patient
becom
increasingli
import
high
sensit
specif
well
speed
albeit
higher
cost
tac
receiv
sporad
support
attend
congress
hain
lifescienci
biomerieux
meridian
